Kang Mo Kim Selected Research

Liver Cirrhosis (Hepatic Cirrhosis)

1/2022	Safety of direct oral anticoagulants compared to warfarin in cirrhotic patients with atrial fibrillation.
8/2016	Clinical significance of fatty liver disease induced by tamoxifen and toremifene in breast cancer patients.
5/2015	Incidence of hepatocellular carcinoma after HBsAg seroclearance in chronic hepatitis B patients: a need for surveillance.
1/2012	Sorafenib dose escalation in the treatment of advanced hepatocellular carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kang Mo Kim Research Topics

Disease

72	Hepatocellular Carcinoma (Hepatoma) 11/2022 - 12/2003
32	Neoplasms (Cancer) 11/2022 - 11/2002
17	Chronic Hepatitis B 03/2022 - 10/2005
14	Fibrosis (Cirrhosis) 12/2021 - 05/2007
9	Liver Diseases (Liver Disease) 01/2015 - 10/2005
8	Liver Neoplasms (Liver Cancer) 01/2019 - 11/2002
6	Cholangiocarcinoma 01/2021 - 03/2009
5	End Stage Liver Disease 12/2021 - 10/2005
4	Hepatitis B 03/2022 - 01/2016
4	Liver Cirrhosis (Hepatic Cirrhosis) 01/2022 - 01/2012
4	Hepatitis 01/2022 - 06/2007
4	Neoplasm Metastasis (Metastasis) 01/2021 - 09/2009
4	Non-alcoholic Fatty Liver Disease 08/2016 - 05/2010
4	Thrombosis (Thrombus) 03/2015 - 04/2012
3	Disease Progression 04/2021 - 07/2005
3	Infections 01/2016 - 10/2009
2	Hepatic Encephalopathy 01/2020 - 03/2008
2	Inflammation (Inflammations) 05/2018 - 01/2018
2	Fatty Liver 08/2016 - 06/2005
2	Chronic Hepatitis C 06/2014 - 03/2013
2	Hypoxia (Hypoxemia) 01/2012 - 03/2005
1	Varicose Veins (Varicose Vein) 01/2022
1	Atrial Fibrillation 01/2022
1	Esophageal and Gastric Varices (Esophageal Varices) 01/2022
1	Hemorrhage 01/2022
1	Prostatic Neoplasms (Prostate Cancer) 01/2022
1	Lymphatic Metastasis 09/2020
1	Ascites 01/2020
1	Dyslipidemias (Dyslipidemia) 01/2019
1	Autoimmune Hepatitis 01/2019

Drug/Important Bio-Agent (IBA)

13	Sorafenib (BAY 43-9006)FDA Link 04/2021 - 11/2011
10	alpha-Fetoproteins (alpha-Fetoprotein)IBA 01/2021 - 12/2007
8	Alanine Transaminase (SGPT)IBA 11/2022 - 05/2010
7	DNA (Deoxyribonucleic Acid)IBA 03/2022 - 09/2011
7	Hepatitis B Surface Antigens (HBsAg)FDA Link 03/2022 - 06/2005
6	Antiviral Agents (Antivirals)IBA 03/2022 - 07/2005
6	Lamivudine (Epivir)FDA Link 01/2016 - 10/2005
6	entecavir FDA Link 01/2016 - 10/2009
4	Hepatitis B e AntigensIBA 03/2022 - 10/2012
4	Proteins (Proteins, Gene)FDA Link 08/2018 - 02/2011
4	Fetal Proteins (Fetoprotein)IBA 04/2017 - 11/2011
3	NucleosidesIBA 01/2022 - 09/2011
3	Serum AlbuminIBA 10/2021 - 05/2015
3	Pharmaceutical PreparationsIBA 04/2021 - 10/2016
3	gadolinium ethoxybenzyl DTPA FDA Link 01/2019 - 04/2015
3	EnzymesIBA 01/2019 - 03/2005
3	Cisplatin (Platino)FDA LinkGeneric 11/2018 - 01/2018
3	InterferonsIBA 04/2016 - 06/2007
3	Ethiodized Oil (Ethiodol)FDA Link 06/2013 - 11/2002
3	adefovir dipivoxil (Hepsera)FDA Link 02/2012 - 10/2005
2	Tenofovir (Viread)FDA Link 03/2022 - 01/2022
2	AntigensIBA 03/2022 - 09/2011
2	Iodized OilIBA 02/2022 - 03/2013
2	lenvatinibIBA 04/2021 - 09/2020
2	NivolumabIBA 07/2020 - 07/2020
2	Biomarkers (Surrogate Marker)IBA 01/2019 - 01/2016
2	Gemcitabine FDA Link 11/2018 - 01/2018
2	CholesterolIBA 01/2018 - 08/2012
2	peginterferon alfa-2a (Pegasys)FDA Link 04/2016 - 03/2013
2	MicroRNAs (MicroRNA)IBA 07/2014 - 05/2014
2	Ribavirin (Virazole)FDA LinkGeneric 06/2014 - 03/2013
2	lipoarabinomannan (LAM)IBA 02/2012 - 06/2006
2	adefovirIBA 10/2009 - 06/2006
2	Bile Acids and Salts (Bile Acids)IBA 08/2006 - 04/2006
1	RNA (Ribonucleic Acid)IBA 11/2022
1	nasIBA 01/2022
1	tenofovir alafenamideIBA 01/2022
1	cabozantinibIBA 01/2022
1	AnticoagulantsIBA 01/2022
1	Cyclopentanes (Cyclopentane)IBA 01/2022
1	Phosphotransferases (Kinase)IBA 01/2022
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2022
1	Warfarin (Coumadin)FDA LinkGeneric 01/2022
1	Organophosphonates (Phosphonates)IBA 01/2022
1	L-Iditol 2-Dehydrogenase (L Iditol 2 Dehydrogenase)IBA 12/2021
1	Argininosuccinate Synthase (Argininosuccinate Synthetase)IBA 04/2021
1	Arginine (L-Arginine)FDA Link 04/2021
1	Bevacizumab (Avastin)FDA Link 04/2021
1	atezolizumabIBA 04/2021
1	regorafenibIBA 07/2020
1	Adenosine Triphosphatases (ATPase)IBA 01/2020
1	CytokinesIBA 01/2019
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2019
1	Immunoglobulin G (IgG)IBA 01/2019
1	Alkaline PhosphataseIBA 11/2018
1	CA-19-9 Antigen (CA 19-9 Antigen)IBA 11/2018
1	Proto-Oncogene Proteins c-rafIBA 08/2018

Therapy/Procedure

27	Therapeutics 04/2021 - 12/2003
11	Radiotherapy 04/2022 - 05/2009
10	Liver Transplantation 01/2020 - 03/2006
5	Drug Therapy (Chemotherapy) 01/2022 - 01/2016
5	Hepatectomy 01/2020 - 03/2009
3	Immunotherapy 01/2022 - 06/2015
3	Radiofrequency Ablation 12/2015 - 07/2009
2	Salvage Therapy 02/2022 - 10/2013
2	Transplantation 12/2021 - 01/2013
2	Retreatment 10/2016 - 10/2012
2	Surgical Instruments (Clip) 12/2015 - 11/2002
2	Conformal Radiotherapy 01/2015 - 04/2012
1	Combination Drug Therapy (Combination Chemotherapy) 04/2021